主管单位:中华人民共和国
国家卫生健康委员会
主办单位:
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Du Qiuyan Jiang Changlian Liu Li Ye Lanxian
英文单位:Department of Mental Health Lanzhou University Second Hospital Lanzhou 730030 China
关键词:纤维肌痛症;米那普仑;研究进展
英文关键词:Fibromyalgia;Milnacipran;Researchprogress
纤维肌痛症也称纤维肌痛综合征,因其广泛的症状学特征和极高的共病率已成为一种高度致残疾病,临床误诊率高,患者极易伴发抑郁情绪而导致病情加重,目前其发病机制尚不明确。米那普仑是一种特异性5-羟色胺和去甲肾上腺素再摄取抑制剂,能同等强度地抑制神经末梢对5-羟色胺和去甲肾上腺素的再摄取,临床上主要用于抑郁症及纤维肌痛症的治疗。本文对米那普仑治疗纤维肌痛症的可能机制、临床效果及安全性等进行综述,以期为米那普仑在纤维肌痛症中的应用提供参考。
Fibromyalgia, also known as fibromyalgia syndrome, has become a highly disabling disease due to its extensive symptomatic characteristics and high rate of comorbidities. The misdiagnosis rate is high, and it is easy to be accompanied by depression, which leads to exacerbation of the condition. At present, the pathogenesis is not clear. Milnacipran is a specific serotonin and norepinephrine reuptake inhibitor, which can inhibit the reuptake of serotonin and norepinephrine by nerve endings with equal intensity. It is mainly used in the clinical treatment of depression and fibromyalgia. This article reviews the possible mechanism, clinical efficacy and safety of milnacipran in the treatment of fibromyalgia, in order to provide reference for the more scientific application of milnacipran in fibromyalgia.
copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。